SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-20-000162
Filing Date
2020-11-03
Accepted
2020-11-03 16:05:59
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20200930.htm   iXBRL 10-Q 855488
2 EX-31.1 lfvn093020ex311.htm EX-31.1 9771
3 EX-31.2 lfvn093020ex312.htm EX-31.2 9579
4 EX-32.1 lfvn093020ex321.htm EX-32.1 5078
5 EX-32.2 lfvn093020ex322.htm EX-32.2 5056
  Complete submission text file 0000849146-20-000162.txt   4032973

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20200930.xsd EX-101.SCH 26223
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20200930_cal.xml EX-101.CAL 64016
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20200930_def.xml EX-101.DEF 111260
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20200930_lab.xml EX-101.LAB 411029
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20200930_pre.xml EX-101.PRE 241342
11 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20200930_htm.xml XML 501087
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 201283528
SIC: 2834 Pharmaceutical Preparations